[Federal Register Volume 63, Number 196 (Friday, October 9, 1998)]
[Notices]
[Page 54494]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-27107]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on September 15, 1998, Research 
Biochemicals, Inc., Limited Partnership, Attn: Richard Milius, 1-3 
Strathmore Road, Natick, Massachusetts 01760, made application by 
letter to the Drug Enforcement Administration (DEA) for registration as 
a bulk manufacturer of cocaine (9041), a basic class of controlled 
substance listed in Schedule II.
    The firm plans to manufacture small quantities of a derivative of 
cocaine.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than December 8, 1998.

    Dated: October 1, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 98-27107 Filed 10-8-98; 8:45 am]
BILLING CODE 4410-09-M